Quantifying Left Atrial Size in the Context of Atrial Fibrillation Ablation: Which Echocardiographic Method Correlates to Outcome of Pulmonary Venous Isolation?

Patrick Leitz; Lena Marie Stebel; Christian Andresen; Christian Ellermann; Fatih Güner; Florian Reinke; Simon Kochhäuser; Gerrit Frommeyer; Julia Köbe; Kristina Wasmer; Philipp S Lange; Stefan Orwat; Lars Eckardt; Dirk G Dechering

doi:10.3390/jpm11090913

Quantifying Left Atrial Size in the Context of Atrial Fibrillation Ablation: Which Echocardiographic Method Correlates to Outcome of Pulmonary Venous Isolation?

J Pers Med. 2021 Sep 13;11(9):913. doi: 10.3390/jpm11090913.

Affiliations

¹ Department of Cardiology II-Electrophysiology, University Hospital Muenster, Cardiol, Albert-Schweitzer-Campus 1, A1, 48149 Muenster, Germany.
² Department of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Cardiol, Albert-Schweitzer-Campus 1, A1, 48149 Muenster, Germany.

Abstract

Introduction: Multiple studies have shown that left atrial (LA) enlargement is a strong predictor of poor outcome after catheter ablation of atrial fibrillation (AF). LA size is commonly approximated as the diameter in the parasternal long axis. It remains unknown whether more precise echocardiographic measurements of LA size allow for better correlation with outcome after pulmonary vein isolation (PVI).

Methods and results: We performed a retrospective study of 131 consecutive patients (43 females, 60% paroxysmal AF, mean CHA2DS2-Vasc score 1.6, mean age 61 ± 12 years) referred for PVI. Measurements of the LA were carried out by a single observer in transthoracic echocardiograms (TTE) performed prior to ablation. We calculated diameter of the LA in the parasternal long axis (PLAX), LA area in the 2- as well as 4-Chamber (CH) view. LA volume was computed using the disc summation technique (LAV) and indexed to body surface area (LAVI). Procedural and follow-up data were gathered from a prospective AF database. Ablation was performed exclusively using the second generation cryoballoon by the same operators. Follow-up visits at 3, 6 and 12 months showed freedom from AF in 76%, 73% and 73% respectively. Mean values of LA calculations were LAPLAX: 37.9 mm ± 6.3 mm, 2CH area: 22.5 cm² ± 6.7 cm², 4CH area: 21.4 cm² ± 5.5 cm², LAV: 73.7 mL ± 26.1 mL and LAVI: 36.2 mL/m² ± 12.7 mL/m², respectively. C statistic revealed the best concordance of LAVI with outcome after 12 months (C = 0.67), LAV also exhibited a satisfactory value (C = 0.61) in comparison to surfaces in 2CH (C = 0.59) and 4CH (C = 0.57). PLAX showed the worst correlation (C = 0.51). Additionally, different binary logistic regression models identified three independent predictors of AF outcome after cryoballoon PVI: gender (OR = 0.95 per year; p = 0.01); LAV (OR = 1.3/10mL; p = 0.02) and LAVI (OR = 1.58/10 mL/m²; p = 0.02). In all models, PLAX and area measurements were not predictive.

Conclusions: Our data add further to evidence that LA size lends itself well as a predictor of PVI outcome. LAVI and LAV were independently predictive of rhythm outcome after PVI. This did not hold true for more commonly used measurements, such as PLAX diameter and surfaces of the LA, irrespective of the view chosen.

Keywords: ablation; atrial fibrillation; echocardiography; left atrium.